Evidence map›Paper›PMID 37217811›Full record

ArticleHeart and vessels2023

Multicenter, retrospective registry of isolated atherosclerotic popliteal arteries treated with endovascular revascularization.

Kazunori Horie, Mitsuyoshi Takahara, Tatsuya Nakama, Akiko Tanaka, Kazuki Tobita, Naoki Hayakawa, Shinsuke Mori, Yo Iwata, Kenji Suzuki

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Kazunori HorieDepartment of Cardiovascular Medicine, Sendai Kousei Hospital, 4-15 Hirose-Cho, Aoba-Ku, Sendai, Miyagi, 980-0873, Japan. horihori1015@gmail.com.ORCID http://orcid.org/0000-0002-8614-7729
Mitsuyoshi TakaharaDepartment of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Tatsuya NakamaDepartment of Cardiology, Tokyobay UrayasuIchikawa Medical Center, Chiba, Japan.
Akiko TanakaDepartment of Cardiovascular Medicine, Sendai Kousei Hospital, 4-15 Hirose-Cho, Aoba-Ku, Sendai, Miyagi, 980-0873, Japan.
Kazuki TobitaDepartment of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
Naoki HayakawaDepartment of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
Shinsuke MoriDepartment of Cardiology, Saiseikai Yokohama City Eastern Hospital, Kanagawa, Japan.
Yo IwataDepartment of Cardiology, Funabashi Municipal Medical Center, Chiba, Japan.
Kenji SuzukiDepartment of Cardiology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Sendai Kousei Hospital · JPAsahi General Hospital · JPFunabashi Municipal Medical Center · JPSaiseikai Central Hospital · JPSaiseikai Yokohama Eastern Hospital · JPShonan Kamakura General Hospital · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolated atherosclerotic popliteal lesions (IAPLs) have been considered challenging. This study aimed to investigate the efficacy of endovascular therapy (EVT) using the newer devices for IAPLs. This retrospective multicenter registry analyzed patients with lower extremity artery disease having IAPLs who underwent EVT using the newer devices between 2018 and 2021. The primary outcome was primary patency 1 year after EVT. A total of 392 consecutive patients undergoing EVT for IAPLs were enrolled. The Kaplan-Meier analysis showed that the primary patency and the freedom from target lesion revascularization were 80.9% and 87.8% 1 year after EVT, respectively. The multivariate Cox proportional hazards regression analysis showed that the clinical features that were independently associated with restenosis risk were drug-coated balloon (DCB) use for younger age (< 75 years old; adjusted hazard ratio, 3.08 [95% confidence interval 1.08-8.74]; P = 0.035), non-ambulatory status (2.74 [95% confidence interval 1.56-4.81]; P < 0.001), cilostazol use (0.51 [95% confidence interval 0.29-0.88]; P = 0.015), severe calcification (1.86 [95% confidence interval 1.18-2.94]; P = 0.007), and small external elastic membrane (EEM) area measured by intravascular ultrasound (IVUS) (< 30 mm

Indexed as

Angioplasty, BalloonAtherosclerosisEndovascular ProceduresPeripheral Arterial DiseaseAgedCoated Materials, BiocompatibleFemoral ArteryHumansPopliteal ArteryRegistriesRetrospective StudiesTreatment OutcomeVascular PatencyCoated Materials, BiocompatibleAngioplastyDrug-coated balloonDrug-eluting stentInterwoven nitinol stentIsolated popliteal artery lesions

Identifiers

PMID37217811
OpenAlexW4377563814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.